The table below shows WEST PHARMACEUTICAL SERVICES INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$844.90M
$804.60M
$766.50M
$698.00M
$746.90M
$702.10M
Cost of revenue
$548.50M
$510.30M
$492.60M
$466.10M
$482.20M
$472.10M
Gross profit
$296.40M
$294.30M
$273.90M
$231.90M
$264.70M
$230.00M
R&D
$15.80M
$17.10M
$19.10M
$16.30M
$15.50M
$17.50M
WST annual revenue (10-K history)
WEST PHARMACEUTICAL SERVICES INC reported annual revenue of $3.07B for fiscal year 2025. That is up 6.3% from $2.89B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.51B (FY 2016) to $3.07B. Figures come from the company's audited annual reports as filed with the SEC.
